Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | BHMT | Q93088 | 1/20 | 0.34 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | KDM6B | O15054 | 1/20 | 0.30 |
| ▸ | KDM5C | P41229 | 1/20 | 0.30 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.30 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.30 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.30 |
| ▸ | KDM5A | P29375 | 1/20 | 0.30 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12601725 | 0.88 | ALDH1A1 (0.46) | ALDH1A1HPGDLMNAKMT2AHSD17B10 | |
| SCHEMBL22853924 | 0.82 | ALDH1A1 (0.44) | ALDH1A1HPGDLMNAKMT2AHSD17B10 | |
| SCHEMBL12601755 | 0.78 | ALDH1A1 (0.53) | ALDH1A1HPGDLMNAKMT2AHSD17B10 | |
| SCHEMBL15495583 | 0.75 | ALDH1A1 (0.41) | ALDH1A1HPGDLMNAKMT2AHSD17B10 | |
| SCHEMBL4569673 | 0.75 | NOD1 (0.40) | — | |
| SCHEMBL10050321 | 0.75 | NOD1 (0.40) | — | |
| SCHEMBL24714503 | 0.73 | ALDH1A1 (0.42) | ALDH1A1HPGDLMNAKMT2AHSD17B10 | |
| SCHEMBL2735600 | 0.73 | ALDH1A1 (0.42) | ALDH1A1HPGDKMT2AHSD17B10TSHR | |
| SCHEMBL24714469 | 0.71 | TSHR (0.47) | ALDH1A1HPGDLMNAKMT2AHSD17B10 | |
| SCHEMBL28612348 | 0.70 | LMNA (0.56) | ALDH1A1HPGDLMNAKMT2AHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160317673-A1 | Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same | SERINA THERAPEUTICS (AL), INC. | 2016-11-03 | — | — | US | disclosed |
| US-9169354-B2 | Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same | SERINA THERAPEUTICS, INC. (US) | 2015-10-27 | — | — | US | disclosed |
| US-20150273074-A1 | Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same | SERINA THERAPEUTICS, INC. | 2015-10-01 | — | — | US | disclosed |
| US-20140066577-A1 | Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same | SERINA THERAPEUTICS, INC. (US) | 2014-03-06 | — | — | US | disclosed |
| US-8501899-B2 | Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same | SERINA THERAPEUTICS, INC. (US) | 2013-08-06 | — | — | US | disclosed |
| US-20120136123-A1 | Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same | SERINA THERAPEUTICS, INC. (US) | 2012-05-31 | — | — | US | disclosed |
| US-20120123055-A1 | Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same | SERINA THERAPEUTICS, INC. (US) | 2012-05-17 | — | — | US | disclosed |
| US-8110651-B2 | Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same | SERINA THERAPEUTICS, INC. (US) | 2012-02-07 | — | — | US | disclosed |
| US-8101706-B2 | Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same | SERINA THERAPEUTICS, INC. (US) | 2012-01-24 | — | — | US | disclosed |
| US-20110009594-A1 | MULTIFUNCTIONAL FORMS OF POLYOXAZOLINE COPOLYMERS AND DRUG COMPOSITIONS COMPRISING THE SAME | SERINA THERAPEUTICS, INC. (US) | 2011-01-13 | — | — | US | disclosed |
| US-20100330023-A1 | Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same | SERINA THERAPEUTICS, INC. (US) | 2010-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160317673-A1 | Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same | ERBB3, ERBB2, PANK2 | ALDH1A1 3859/4885HPGD 1131/4885LMNA 4630/4885 |
| US-20100330023-A1 | Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same | ERBB3, ERBB2, PANK2 | ALDH1A1 3859/4885HPGD 1131/4885LMNA 4630/4885 |
| US-20150273074-A1 | Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same | ERBB3, ERBB2, PANK2 | ALDH1A1 3805/4885HPGD 1177/4885LMNA 4609/4885 |
| US-20140066577-A1 | Multifunctional Forms of Polyoxazoline Copolymers and Drug Compositions Comprising the Same | ERBB3, ERBB2, PANK2 | ALDH1A1 3859/4885HPGD 1131/4885LMNA 4630/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.